LOX family members are upregulated in a number of different cancer types, and high levels of LOX family expression, as well as elevated deposition of fibrillar collagen in tumours, is associated with poor patient outcomes (see Table 1 and Table 2) [42,43,44,45]. This evidence concerns the gene LOX and cancer.